Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 340 of 6351
-
New light treatment could fight oral cancer without surgery
Disease control Not yet recruitingThe primary goal of this study is to see if photodynamic therapy (PDT) is effective for treatment of lesions in the oral cavity which have high risk of becoming oral cancer. PDT treatment uses a drug, called a photosensitizer, which makes the diseased cells become light-sensitive…
Phase 2 • Sponsor: University of Massachusetts, Boston • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New Weight-Loss drug bofanglutide takes on semaglutide in major trial
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy and safety of Bofanglutide (GZR18) compared with Semaglutide in Latin American adults with overweight or obesity. It will also evaluate the effects of treatment on metabolic parameters, cardiovascular risk factors, and q…
Phase 3 • Sponsor: Carnot Laboratories • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New oral drug aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowA multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Ponesimod (VSP-128) in patients with moderately to severely active ulcerative colitis
Phase 3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Zapping nerves with radiation may ease pancreatic cancer pain
Symptom relief Not yet recruitingPain from advanced pancreatic cancer is often difficult to control. This pain commonly occurs when the cancer affects a network of nerves in the abdomen called the coeliac plexus. Even strong pain medicines, including morphine and related drugs, may not give enough relief. Some p…
Phase 2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Genetic blood test could spare many pregnancies from unnecessary monitoring
Diagnosis Not yet recruitingDetermination of Fetal Blood Group by Next-Generation Sequencing - A Clinical Study in Pregnancies with Maternal Alloantibodies Directed Against Fetal Blood Cells (Alloimmunization During Pregnancy) Maternal antibodies can cross the placenta and reach the fetus during pregnancy.…
Sponsor: Karolinska University Hospital • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Brain scans face off: can a quick CT match MRI's accuracy in stroke care?
Diagnosis Not yet recruitingAcute ischemic stroke (AIS) is a leading cause of death and long-term disability worldwide. In patients with suspected large vessel occlusion, rapid diagnosis and reperfusion therapy are critical, as treatment delays are associated with worse functional outcomes and increased mor…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Can a JAK inhibitor halt rapid lung decline?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether adding the JAK inhibitor golidocitinib to standard corticosteroid therapy works to treat rapidly progressive interstitial lung disease (RP-ILD) in patients with acute worsening. It will also learn about its safety compared to st…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Smartphone apps and wearables could transform heart recovery
Disease control Not yet recruitingThe purpose of the BRIDGE study is to learn whether supplementing traditional center-based cardiac rehabilitation (CBCR) with a mobile health technology intervention can help patients monitor their health, stay engaged in healthy lifestyle behaviors, better manage cardiovascular …
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a smaller incision speed recovery after heart bypass in frail seniors?
Disease control Not yet recruitingFrailty is a major predictor of adverse outcomes following coronary artery bypass grafting (CABG), being associated with increased postoperative complications, prolonged hospitalization, delayed functional recovery, and reduced quality of life. Although minimally invasive coronar…
Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Olive oil compounds may shield the aging brain from memory decline
Prevention Not yet recruitingThe goal of this clinical trial is to determine whether the extra-virgin olive oil (EVOO) phenolic dietary supplement can improve memory function and modulate biomarkers among individuals with mild cognitive impairment (MCI). The main questions it aims to answer are: * Does diet…
Sponsor: Augusta University • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Can a Two-Drug combo beat a stubborn stomach bug?
Disease control Not yet recruitingInvestigators will enroll treatment-naïve H. pylori-positive patients according to the inclusion and exclusion criteria in the trial. After obtaining written informed consent, investigators will open envelopes labeled with corresponding subject numbers in the order of subject enr…
Phase 4 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Ear acupressure: a new weapon against chemotherapy side effects?
Prevention Not yet recruitingChemotherapy-induced nausea and vomiting (CINV) remains one of the most common and distressing adverse effects in patients receiving highly emetogenic chemotherapy (HEC). Despite the widespread use of guideline-recommended triple antiemetic therapy, a substantial proportion of pa…
Sponsor: China Medical University, China • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
Coloring your way through labor: a simple art activity may tame birth fear
Symptom relief Not yet recruitingThis randomized controlled trial aims to evaluate whether a mandala coloring activity during labor can reduce birth anxiety and fear of childbirth among primiparous pregnant women experiencing their first birth. The study will be conducted among eligible primiparous women admitte…
Sponsor: Ataturk University • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a daily eye gel replace injections for wet AMD?
Disease control Not yet recruitingThis is a first-in-human clinical trial evaluating the safety and tolerability of BETA-TT8 Ophthalmic Gel in people with wet age-related macular degeneration (AMD). Approximately 24 participants with stable wet AMD who have previously received at least three anti- Vascular Endoth…
Phase 1/2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a new pill silence stubborn hives?
Disease control Not yet recruitingTHB335-201 is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group, multicenter study in adults with CSU who remain symptomatic despite standard-of-care treatment. The study includes a Screening Period of up to 4 weeks, a 12-week Treatment Period, and a 4-week …
Phase 2 • Sponsor: Calixis Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could simple guidelines cut ICU anemia deaths?
Disease control Not yet recruitingSTOP-A is a prospective, multicenter data study aimed at demonstrating the impact of multifaceted support for the implementation of recommendations on the prevention and management of anemia in intensive care, compared to previous practices, on hospital mortality in adult patient…
Sponsor: University Hospital, Angers • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Protein and saline mist may cut bleeding risk after tonsil removal
Disease control Not yet recruitingTonsillectomy is one of the most common surgical procedures performed on both pediatric and adult patients; it is frequently associated with significant postoperative pain, difficulty swallowing, and the risk of complications such as bleeding and infection. The recovery period re…
Phase 3 • Sponsor: Hospital Felicio Rocho • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
A diet tweak may boost platelets in a bleeding disorder
Disease control Not yet recruitingThis randomized controlled trial aims to evaluate the effect of a selective Mediterranean diet regimen, used as an adjunct to standard therapy, on platelet count and bleeding-related outcomes in adult patients with primary immune thrombocytopenia (ITP).
Sponsor: Assiut University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
AI chatbot may calm nerves after a prostate cancer diagnosis
Symptom relief Not yet recruitingThe purpose of this multicenter, open-label, randomized controlled trial is to evaluate whether patient-centered support delivered through a large language model (LLM)-based artificial intelligence (AI) agent reduces anxiety in patients with newly diagnosed metastatic hormone-sen…
Sponsor: Fudan University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection help tackle obesity? a trial puts it to the test
Disease control Not yet recruitingThe main purpose of this study is to assess how well LY4329090 is tolerated and what side effects may occur in healthy participants with obesity or overweight. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the bo…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC